Regulation of ERK2 Activity by Dynamic S-acylation

Overview

Journal Cell Rep

Publisher Cell Press

Specialties Biology
Cell Biology
Molecular Biology

Date 2023 Sep 16

PMID 37715953

Authors

Saara-Anne Azizi

Tian Qiu

Noah E Brookes

Bryan C Dickinson

Affiliations

Soon will be listed here.

Abstract

Extracellular signal-regulated kinases (ERK1/2) are key effector proteins of the mitogen-activated protein kinase pathway, choreographing essential processes of cellular physiology. Here, we discover that ERK1/2 are subject to S-acylation, a reversible lipid modification of cysteine residues, at C271/C254. The levels of ERK1/2 S-acylation are modulated by epidermal growth factor (EGF) signaling, mirroring its phosphorylation dynamics, and acylation-deficient ERK2 displays altered phosphorylation patterns. We show that ERK1/2 S-acylation is mediated by "writer" protein acyl transferases (PATs) and "eraser" acyl protein thioesterases (APTs) and that chemical inhibition of either lipid addition or removal alters ERK1/2's EGF-triggered transcriptional program. Finally, in a mouse model of metabolic syndrome, we find that ERK1/2 lipidation levels correlate with alterations in ERK1/2 lipidation writer/eraser expression, solidifying a link between ERK1/2 activity, ERK1/2 lipidation, and organismal health. This study describes how lipidation regulates ERK1/2 and offers insight into the role of dynamic S-acylation in cell signaling more broadly.

Citing Articles

Regulation of pattern recognition receptor signaling by palmitoylation.

Li X, Hu X, You H, Zheng K, Tang R, Kong F iScience. 2025; 28(2):111667.

PMID: 39877903 PMC: 11772949. DOI: 10.1016/j.isci.2024.111667.

MicroRNA-145-5p inhibits the tumorigenesis of breast cancer through SENP2-regulated ubiquitination of ERK2.

Chen X, Li D, Su Q, Ling X, Ding S, Xu R Cell Mol Life Sci. 2024; 81(1):461.

PMID: 39578257 PMC: 11584840. DOI: 10.1007/s00018-024-05505-8.

Mechanisms and functions of protein S-acylation.

S Mesquita F, Abrami L, Linder M, Bamji S, Dickinson B, van der Goot F Nat Rev Mol Cell Biol. 2024; 25(6):488-509.

PMID: 38355760 DOI: 10.1038/s41580-024-00700-8.

Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo.

Clerk A, Meijles D, Hardyman M, Fuller S, Chothani S, Cull J Biochem J. 2022; 479(3):401-424.

PMID: 35147166 PMC: 8883496. DOI: 10.1042/BCJ20210615.

References

Peti W, Page R . Molecular basis of MAP kinase regulation. Protein Sci. 2013; 22(12):1698-710. PMC: 3843625. DOI: 10.1002/pro.2374. View

Lin D, Conibear E . ABHD17 proteins are novel protein depalmitoylases that regulate N-Ras palmitate turnover and subcellular localization. Elife. 2015; 4:e11306. PMC: 4755737. DOI: 10.7554/eLife.11306. View

Plotnikov A, Flores K, Maik-Rachline G, Zehorai E, Kapri-Pardes E, Berti D . The nuclear translocation of ERK1/2 as an anticancer target. Nat Commun. 2015; 6:6685. DOI: 10.1038/ncomms7685. View

Cohen P, Klumpp S, Schelling D . An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues. FEBS Lett. 1989; 250(2):596-600. DOI: 10.1016/0014-5793(89)80803-8. View

Niphakis M, Lum K, Cognetta 3rd A, Correia B, Ichu T, Olucha J . A Global Map of Lipid-Binding Proteins and Their Ligandability in Cells. Cell. 2015; 161(7):1668-80. PMC: 4615699. DOI: 10.1016/j.cell.2015.05.045. View

Tai W, Yong W, Lim C, Low L, Tham C, Koh T . A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC). Ann Oncol. 2016; 27(12):2210-2215. DOI: 10.1093/annonc/mdw415. View

Cao Y, Qiu T, Kathayat R, Azizi S, Thorne A, Ahn D . ABHD10 is an S-depalmitoylase affecting redox homeostasis through peroxiredoxin-5. Nat Chem Biol. 2019; 15(12):1232-1240. PMC: 6871660. DOI: 10.1038/s41589-019-0399-y. View

Karmi A, Iozzo P, Viljanen A, Hirvonen J, Fielding B, Virtanen K . Increased brain fatty acid uptake in metabolic syndrome. Diabetes. 2010; 59(9):2171-7. PMC: 2927939. DOI: 10.2337/db09-0138. View

Charron G, Zhang M, Yount J, Wilson J, Raghavan A, Shamir E . Robust fluorescent detection of protein fatty-acylation with chemical reporters. J Am Chem Soc. 2009; 131(13):4967-75. DOI: 10.1021/ja810122f. View

10.

Bi L, Chiang J, Ding W, Dunn W, Roberts B, Li T . Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice. J Lipid Res. 2013; 54(10):2754-62. PMC: 3770088. DOI: 10.1194/jlr.M039347. View

11.

Azizi S, Lan T, Delalande C, Kathayat R, Banales Mejia F, Qin A . Development of an Acrylamide-Based Inhibitor of Protein -Acylation. ACS Chem Biol. 2021; 16(8):1546-1556. PMC: 8590885. DOI: 10.1021/acschembio.1c00405. View

12.

Webb Y, Resh M . Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids. J Biol Chem. 2000; 275(1):261-70. DOI: 10.1074/jbc.275.1.261. View

13.

Chang F, Steelman L, Lee J, Shelton J, Navolanic P, Blalock W . Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia. 2003; 17(7):1263-93. DOI: 10.1038/sj.leu.2402945. View

14.

Miao L, Tian H . Development of ERK1/2 inhibitors as a therapeutic strategy for tumour with MAPK upstream target mutations. J Drug Target. 2019; 28(2):154-165. DOI: 10.1080/1061186X.2019.1648477. View

15.

Ozaki K, Awazu M, Tamiya M, Iwasaki Y, Harada A, Kugisaki S . Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes. Am J Physiol Endocrinol Metab. 2016; 310(8):E643-E651. DOI: 10.1152/ajpendo.00445.2015. View

16.

Jiang H, Zhang X, Chen X, Aramsangtienchai P, Tong Z, Lin H . Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies. Chem Rev. 2018; 118(3):919-988. PMC: 5985209. DOI: 10.1021/acs.chemrev.6b00750. View

17.

Kathayat R, Elvira P, Dickinson B . A fluorescent probe for cysteine depalmitoylation reveals dynamic APT signaling. Nat Chem Biol. 2016; 13(2):150-152. PMC: 5247352. DOI: 10.1038/nchembio.2262. View

18.

Sadeghi R, Kulej K, Kathayat R, Garcia B, Dickinson B, Brady D . Wnt5a signaling induced phosphorylation increases APT1 activity and promotes melanoma metastatic behavior. Elife. 2018; 7. PMC: 5919757. DOI: 10.7554/eLife.34362. View

19.

Blaustein M, Piegari E, Calejman C, Vila A, Amante A, Manese M . Akt Is S-Palmitoylated: A New Layer of Regulation for Akt. Front Cell Dev Biol. 2021; 9:626404. PMC: 7917195. DOI: 10.3389/fcell.2021.626404. View

20.

Qiu T, Kathayat R, Cao Y, Beck M, Dickinson B . A Fluorescent Probe with Improved Water Solubility Permits the Analysis of Protein S-Depalmitoylation Activity in Live Cells. Biochemistry. 2017; 57(2):221-225. PMC: 5823605. DOI: 10.1021/acs.biochem.7b00835. View